“Long-Term Safety and Efficacy of Roflumilast Cream 0.3% in Adult Patients With Chronic Plaque Psoriasis: Results From a 52-Week, Phase 2b Open-Label Study”. SKIN The Journal of Cutaneous Medicine, vol. 5, no. 6, Nov. 2021, p. s44, https://doi.org/10.25251/skin.5.supp.44.